Abstract:Objective: This study focused on the ALS5/SPG11/KIAA1840 screening in 28 unrelated pedigrees with autosomal recessive axonal form of Charcot-Marie-Tooth disease (ARCMT2), recruited in Italy, Brazil, Canada, England, Iran, and Japan. Background: Mutations in the ALS5/SPG11/KIAA1840 gene are common cause of autosomal recessive form of hereditary spastic paraplegia (ARHSP) with thin corpus callosum (TCC) and account for approximately 40[percnt] of autosomal recessive juvenile amyotrophic lateral sclerosis (ARJALS). We extended the genetic analyses of ALS5/SPG11/KIAA1840 to CMT patients, especially those with the AR axonal form. Design/Methods: The diagnosis was based on clinical findings and familiar history. Clinical and instrumental functional analyses consist of neurological assessment, neuroimaging, electroneurographic assay, and sural nerve biopsy. Molecular studies include linkage analysis, Sanger sequencing, RFLP analysis, and bioinformatics. Results: All known ARCMT2 loci, genes causing ARHSP with TCC and genes causing ARCMT2, as well as the causative gene of peripheral neuropathy with or without agenesis of the corpus callosum were screened out. Linkage study of all families showed homozygous haplotypes and produced positive logarithm of odds score in all affected subjects. Sanger sequencing identified 15 ALS5/SPG11/KIAA1840 pathological mutations in 12 families. All pathological sequence changes were absent in controls. Two mutations were never reported before and in silico analysis predicted their pathogenetic effect. Co-segregation of each mutation with the disease was confirmed. Conclusions: Our results indicate that ALS5/SPG11/KIAA1840 is the causative gene of a wide spectrum of clinical features, including ARCMT2. Disclosure: Dr. Montecchiani has nothing to disclose. Dr. Pedace has nothing to disclose. Dr. Lo Giudice has nothing to disclose. Dr. Casella has nothing to disclose. Dr. Mearini has nothing to disclose. Dr. Gaudiello has nothing to disclose. Dr. Pedroso has nothing to disclose. Dr. Terracciano has nothing to disclose. Dr. Caltagirone has nothing to disclose. Dr. Massa has nothing to disclose. Dr. St George-Hyslop has nothing to disclose. Dr. Barsottini has nothing to disclose. Dr. Kawarai has nothing to disclose. Dr. Orlacchio has nothing to disclose.

Clinical features and molecular genetic investigation of infantile-onset ascending hereditary spastic paralysis (IAHSP) in two Chinese siblings caused by a novel splice site ALS2 variation

Mutation and Clinical Characteristics of Autosomal-Dominant Hereditary Spastic Paraplegias in China

Molecular genetics study of hereditary spastic paraplegia accompanied by distal amyotrophy-an update

SPTAN1 Variants Likely Cause Autosomal Recessive Complicated Hereditary Spastic Paraplegia

Clinical Features of Hereditary Spastic Paraplegia with Thin Corpus Callosum: Report of 5 Chinese Cases.

Genetic Analysis of SPG4 and SPG3A Genes in a Cohort of Chinese Patients with Hereditary Spastic Paraplegia.

The investigation of genetic and clinical features in Chinese patients with juvenile amyotrophic lateral sclerosis.

Novel variants in AP4B1 cause spastic tetraplegia, moderate psychomotor development delay and febrile seizures in a Chinese patient: a case report

Investigation of a Fused in Sarcoma Splicing Mutation in a Chinese Amyotrophic Lateral Sclerosis Patient.

Personalized Treatment for Infantile Ascending Hereditary Spastic Paralysis Based on In Silico Strategies

Genetic, clinical and neuroimaging profiles of sporadic and autosomal recessive hereditary spastic paraplegia cases in Chinese

Clinical Features and Cu/Zn Superoxide Dismutase Gene Mutations in Two Mainland Chinese Families with Amyotrophic Lateral Sclerosis

Clinical features and genetic spectrum of Chinese patients with hereditary spastic paraplegia: A 14-year study

Novel Compound Missense and Intronic Splicing Mutation in ALDH18A1 Causes Autosomal Recessive Spastic Paraplegia

Clinical Features and Genetic Spectrum in Chinese Patients with Recessive Hereditary Spastic Paraplegia

ITPR1 variant-induced autosomal dominant hereditary spastic paraplegia in a Chinese family

Identification of ALS5/SPG11/ KIAA1840 Mutations in Patients with Autosomal Recessive Form of Charcot-Marie-Tooth Disease Type 2 (S44.002)

Analysis of KIAA0196 gene mutation in a family with hereditary spastic paraplegia

Genotype-phenotype correlation in seven motor neuron disease families with novel ALS2 mutations

A novel variant (p.A524P) in Spastin is responsible for a Chinese family with hereditary spastic paraplegia

ALS2-related disorders in Spanish children